Condition: Multiple Sclerosis (MS) · Relapsing-remitting Multiple Sclerosis (RRMS) · Secondary-progressive Multiple Sclerosis (SPMS) · Sponsor: University Hospital, Basel, Switzerland
This project is to: 1. Quantify differences in axonal integrity and organization in aMS versus naPMS patients. 2. Quantify changes in axonal integrity and organization in aMS versus naPMS patients over a two-year period. 3. Validate the combination of imaging parameters that best differentiate aMS versus naPMS patients using histopathology.
This description comes directly from the study's public registry record.
Cristina Granziera, Prof. Dr. med. · +41 61-32 85 665 · cristina.granziera@usb.ch
Always discuss trial participation with your own doctor first.
| University Hospital Basel, Department of Neurology | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05177523